140 related articles for article (PubMed ID: 2673548)
1. Expression of CD9 antigen on normal activated human B cells.
Zeleznik-Le NJ; Metzgar RS
Cell Immunol; 1989 Oct; 123(1):70-82. PubMed ID: 2673548
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD9 (p24) antigen on hematopoietic cells following treatment with phorbol ester.
Yasukawa M; Hato T; Inatsuki A; Kobayashi Y
Acta Haematol; 1988; 79(3):133-6. PubMed ID: 3128036
[TBL] [Abstract][Full Text] [Related]
3. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody.
Suzuki T; Butler JL; Cooper MD
J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946
[TBL] [Abstract][Full Text] [Related]
4. CD9 expression enhances the susceptibility of myeloma cell lines to cell-mediated cytolysis.
Shallal S; Kornbluth J
Blood; 2000 Jul; 96(1):224-33. PubMed ID: 10891455
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction between B cell subpopulations defined by CD23 expression.
Armitage RJ; Goff LK
Eur J Immunol; 1988 Nov; 18(11):1753-60. PubMed ID: 2974422
[TBL] [Abstract][Full Text] [Related]
6. Induction of surface marker changes and monoclonal idiotypic immunoglobulin secretion in lymphoma/leukemia cells: comparative study with interleukin-1, interleukin-2, interleukin-4, 8-bromo-guanosine, pokeweed mitogen, and tetradecanoyl phorbol-13-acetate.
Gazitt Y; Gangavalli A; Thurman GB
Mol Biother; 1989; 1(6):297-304. PubMed ID: 2610949
[TBL] [Abstract][Full Text] [Related]
7. Studies on the role of CD43 in human B-cell activation and differentiation.
Wikén M; Björck P; Axelsson B; Perlmann P
Scand J Immunol; 1989 Mar; 29(3):353-61. PubMed ID: 2785706
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the expression of IL 2 receptors by human T and B cells: induction by the polyclonal mitogens, phorbol myristate acetate, and anti-mu antibody.
Suzuki T; Cooper MD
J Immunol; 1985 May; 134(5):3111-9. PubMed ID: 2580014
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD5 and CD38 by human CD5- B cells: requirement for special stimuli.
Zupo S; Dono M; Massara R; Taborelli G; Chiorazzi N; Ferrarini M
Eur J Immunol; 1994 Jun; 24(6):1426-33. PubMed ID: 7515814
[TBL] [Abstract][Full Text] [Related]
10. Distribution of cell surface glycoprotein CD9 (P24) antigen on megakaryocyte lineage leukemias and cell lines.
Imamura N; Mtasiwa DM; Ota H; Inada T; Kuramoto A
Am J Hematol; 1990 Sep; 35(1):65-7. PubMed ID: 2389771
[TBL] [Abstract][Full Text] [Related]
11. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).
Ledbetter JA; Shu G; Gallagher M; Clark EA
J Immunol; 1987 Feb; 138(3):788-94. PubMed ID: 3492534
[TBL] [Abstract][Full Text] [Related]
13. The p24 leucocyte membrane antigen: modulation associated with lymphocyte activation and differentiation.
Zola H; Furness V; Barclay S; Zowtyj H; Smith M; Melo JV; Neoh SH; Bradley J
Immunol Cell Biol; 1989 Feb; 67 ( Pt 1)():63-70. PubMed ID: 2785956
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of AIM, an activation inducer molecule of human lymphocytes, is dependent on the activation of protein kinase C.
Cebrián M; Redondo JM; López-Rivas A; Rodríguez-Tarduchy G; De Landázuri MO; Sánchez-Madrid F
Eur J Immunol; 1989 May; 19(5):809-15. PubMed ID: 2786811
[TBL] [Abstract][Full Text] [Related]
15. TPA (12-O-tetradecanoyl-phorbol-13-acetate) activation and differentiation of human peripheral B lymphocytes.
Aman P; Gordon J; Klein G
Immunology; 1984 Jan; 51(1):27-34. PubMed ID: 6606617
[TBL] [Abstract][Full Text] [Related]
16. Homotypic aggregation of pre-B leukemic cell lines by antibodies to VLA integrins correlates with their expression of CD9.
Letarte M; Seehafer JG; Greaves A; Masellis-Smith A; Shaw AR
Leukemia; 1993 Jan; 7(1):93-103. PubMed ID: 7678118
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of an early activation marker restricted to human B cells.
Kikutani H; Kimura R; Nakamura H; Sato R; Muraguchi A; Kawamura N; Hardy RR; Kishimoto T
J Immunol; 1986 Jun; 136(11):4019-26. PubMed ID: 3084651
[TBL] [Abstract][Full Text] [Related]
18. Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor.
Muraguchi A; Butler JL; Kehrl JH; Fauci AS
J Exp Med; 1983 Feb; 157(2):530-46. PubMed ID: 6401797
[TBL] [Abstract][Full Text] [Related]
19. Stimulus-response coupling in human platelets activated by monoclonal antibodies to the CD9 antigen, a 24 kDa surface-membrane glycoprotein.
Carroll RC; Worthington RE; Boucheix C
Biochem J; 1990 Mar; 266(2):527-35. PubMed ID: 2317202
[TBL] [Abstract][Full Text] [Related]
20. Expression of the human B-cell surface protein CD20: alteration by phorbol 12-myristate 13-acetate.
Valentine MA; Cotner T; Gaur L; Torres R; Clark EA
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8085-9. PubMed ID: 3500472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
